Literature DB >> 21306479

Monocarboxylate transporters 1 and 4 are involved in the invasion activity of human lung cancer cells.

Hiroto Izumi1, Mayu Takahashi, Hidetaka Uramoto, Yoshifumi Nakayama, Tsunehiro Oyama, Ke-Yong Wang, Yasuyuki Sasaguri, Shigeru Nishizawa, Kimitoshi Kohno.   

Abstract

Cancer cells show constitutive upregulation of glycolysis, and the concentration of lactate thus produced correlates with prognosis. Here, we examined whether lactate concentration and lactate transporter expression are related to migration and invasion activity. We found that the expression of the monocarboxylate transporters MCT1 and MCT4, but not MCT5, in human lung cancer cell lines was significantly correlated with invasiveness. To clarify the effects of MCT1 and MCT4 expression on invasion, we performed migration and invasion assays after transfection with siRNA specific for MCT1 or MCT4. Knockdown of MCT1 or MCT4 did not influence cell migration but reduced invasion; this was also observed for knockdown of the lactate transporter-associated protein basigin. We also demonstrated that both expression and activity of MMP9 and MMP2 were not correlated with invasion activity and not regulated by MCT1, MCT4 and basigin. Furthermore, the addition of lactate did not increase migration and invasion activity, but low concentration of 4,4'-diisothiocyanatostilbene-2,2'-disulphonic acid (DIDS), a general anion channel blocker, as well as other MCT inhibitors quercetin and simvastatin, inhibited cell invasion without influencing migration activity and the cellular expression of MCT1 and MCT4. This is the first report suggesting that lactate transporters are involved in human cancer cell invasiveness. As such, these proteins may be promising targets for the prevention of cancer invasion and metastasis.
© 2011 Japanese Cancer Association.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21306479     DOI: 10.1111/j.1349-7006.2011.01908.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  70 in total

Review 1.  Role of monocarboxylate transporters in human cancers: state of the art.

Authors:  Céline Pinheiro; Adhemar Longatto-Filho; João Azevedo-Silva; Margarida Casal; Fernando C Schmitt; Fátima Baltazar
Journal:  J Bioenerg Biomembr       Date:  2012-02       Impact factor: 2.945

Review 2.  Targeting lactate metabolism for cancer therapeutics.

Authors:  Joanne R Doherty; John L Cleveland
Journal:  J Clin Invest       Date:  2013-09-03       Impact factor: 14.808

3.  In Vitro and In Vivo Efficacy of AZD3965 and Alpha-Cyano-4-Hydroxycinnamic Acid in the Murine 4T1 Breast Tumor Model.

Authors:  Xiaowen Guan; Marilyn E Morris
Journal:  AAPS J       Date:  2020-06-11       Impact factor: 4.009

Review 4.  Targeting Cancer Metabolism and Current Anti-Cancer Drugs.

Authors:  Witchuda Sukjoi; Jarunya Ngamkham; Paul V Attwood; Sarawut Jitrapakdee
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Differential killing and radio-modifying effects of iodoacetate in mammalian normal and cancer cells.

Authors:  Usha Yadav; K B Anjaria; Rajesha Nairy; K B Shirsath; Utkarsha N Desai; Rajesh K Chaurasia; Nagesh N Bhat; B K Sapra
Journal:  Radiat Environ Biophys       Date:  2017-06-13       Impact factor: 1.925

Review 6.  Warburg meets autophagy: cancer-associated fibroblasts accelerate tumor growth and metastasis via oxidative stress, mitophagy, and aerobic glycolysis.

Authors:  Stephanos Pavlides; Iset Vera; Ricardo Gandara; Sharon Sneddon; Richard G Pestell; Isabelle Mercier; Ubaldo E Martinez-Outschoorn; Diana Whitaker-Menezes; Anthony Howell; Federica Sotgia; Michael P Lisanti
Journal:  Antioxid Redox Signal       Date:  2011-11-17       Impact factor: 8.401

Review 7.  Dysregulated pH in Tumor Microenvironment Checkmates Cancer Therapy.

Authors:  Jaleh Barar; Yadollah Omidi
Journal:  Bioimpacts       Date:  2013-12-10

8.  GalNAc-T6 in the relationship with invasion ability of endometrial carcinomas and prognostic significance.

Authors:  Thuy Thi Nguyen; Tomoko Kurita; Chiho Koi; Midori Murakami; Seiji Kagami; Toru Hachisuga; Hisaoka Masanori; Yasuo Morimoto; Hiroto Izumi
Journal:  Am J Cancer Res       Date:  2017-05-01       Impact factor: 6.166

9.  Polymorphisms of monocarboxylate transporter genes are associated with clinical outcomes in patients with colorectal cancer.

Authors:  Fei Fei; Xu Guo; Yibing Chen; Xiaonan Liu; Jianfei Tu; Jinliang Xing; Zhinan Chen; Jiansong Ji; Xianli He
Journal:  J Cancer Res Clin Oncol       Date:  2014-12-10       Impact factor: 4.553

10.  Monocarboxylate transporters (MCTs) in gliomas: expression and exploitation as therapeutic targets.

Authors:  Vera Miranda-Gonçalves; Mrinalini Honavar; Céline Pinheiro; Olga Martinho; Manuel M Pires; Célia Pinheiro; Michelle Cordeiro; Gil Bebiano; Paulo Costa; Isabel Palmeirim; Rui M Reis; Fátima Baltazar
Journal:  Neuro Oncol       Date:  2012-12-20       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.